AlloVir (ALVR) has issued an update.
AlloVir, Inc.’s board, guided by its compensation committee, has sanctioned a potential $100,000 cash bonus for three top executives, contingent on sealing a change of control deal within the 2024 fiscal year. The bonuses hinge on both the successful negotiation of this strategic transaction and the executives remaining with the company until its completion. Notably, the CEO and CFO did not participate in the vote concerning their own bonuses.
See more data about ALVR stock on TipRanks’ Stock Analysis page.
